Skip to main content
. 2023 Sep 19;13(9):607–619. doi: 10.5498/wjp.v13.i9.607

Table 3.

Development of deep transcranial magnetic stimulation in Schizophrenia

Ref.
Method
Result
Adverse events
Significance
Birdi et al[36], 2023 1 Hz DTMS stimulates LTPC Significant improvement in AHRS score Transient headache DTMS treatment was effective for chronic auditory hallucinations in schizophrenic patients
Rosenberg et al[38], 2011 20 Hz DTMS stimulates PFC Cognition and negative symptoms are improved Transient headache and fatigue DTMS can improve negative symptoms and cognitive deficits for schizophrenia patients
Rosenberg et al[38], 2011 1 Hz DTMS stimulates LTPC Significant improvement in AHRS score Mild and self-limiting headaches DTMS had no significant effect on auditory hallucinations
Rabany et al[43], 2014 20 Hz DTMS stimulates PFC SANS was significantly reduced Unreported DTMS was effective for negative symptoms, but the effect was moderate
Linsambarth et al[44], 2019 18 Hz DTMS stimulates bilateral PFC SANS was significantly reduced Temporary headaches, scalp aches, and toothaches DTMS contributed to negative symptoms in schizophrenia
Moeller et al[42], 2022 10 HZ DTMS stimulates the insular and prefrontal cortices The DTMS group had a more pronounced decrease in insula blood flow than the sham operation group Unreported DTMS in smoking patients with schizophrenia was effective

AHRS: Auditory Hallucinations Rating Scale; DTMS: Deep transcranial magnetic stimulation; PFC: Prefrontal cortex; SANS: Scale for the Assessment of Negative Symptoms; TPC: Temporoparietal cortex.